[HTML][HTML] Prostate cancer histopathology using label-free multispectral deep-UV microscopy quantifies phenotypes of tumor aggressiveness and enables multiple …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li, Q Dai… - Scientific Reports, 2022 - nature.com
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …

Prostate cancer histopathology using label-free multispectral deep-UV microscopy quantifies phenotypes of tumor aggressiveness and enables multiple diagnostic …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li… - Scientific …, 2022 - ui.adsabs.harvard.edu
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …

[HTML][HTML] Prostate cancer histopathology using label-free multispectral deep-UV microscopy quantifies phenotypes of tumor aggressiveness and enables multiple …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li, Q Dai… - Scientific …, 2022 - ncbi.nlm.nih.gov
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …

Prostate Cancer Histopathology Using Label-free Multispectral Deep-UV Microscopy Quantifies Phenotypes of Tumor Aggressiveness and Enables Multiple …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li, Q Dai… - 2021 - researchsquare.com
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …

Prostate cancer histopathology using label-free multispectral deep-UV microscopy quantifies phenotypes of tumor aggressiveness and enables multiple diagnostic …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li… - Scientific …, 2022 - search.ebscohost.com
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …

Prostate cancer histopathology using label-free multispectral deep-UV microscopy quantifies phenotypes of tumor aggressiveness and enables multiple diagnostic …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li… - Scientific …, 2022 - pubmed.ncbi.nlm.nih.gov
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …

Prostate cancer histopathology using label-free multispectral deep-UV microscopy quantifies phenotypes of tumor aggressiveness and enables multiple diagnostic …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li, Q Dai… - Scientific …, 2022 - europepmc.org
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …

Prostate cancer histopathology using label-free multispectral deep-UV microscopy quantifies phenotypes of tumor aggressiveness and enables multiple diagnostic …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li, Q Dai… - Scientific Reports, 2022 - par.nsf.gov
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …

[PDF][PDF] Prostate Cancer Histopathology Using Label-free Multispectral Deep-UV Microscopy Quantifies Phenotypes of Tumor Aggressiveness and Enables Multiple …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li, Q Dai… - scholar.archive.org
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …

Prostate Cancer Histopathology Using Label-free Multispectral Deep-UV Microscopy Quantifies Phenotypes of Tumor Aggressiveness and Enables Multiple …

S Soltani, A Ojaghi, H Qiao, N Kaza, X Li, Q Dai… - 2021 - europepmc.org
Identifying prostate cancer patients that are harboring aggressive forms of prostate cancer
remains a significant clinical challenge. Here we develop an approach based on …